| Ms Kari Odquist Kohl, CNM | |
|
21 Dupont Ave, White Plains, NY 10605-3537 | |
| (914) 686-0406 | |
| Not Available |
| Full Name | Ms Kari Odquist Kohl |
|---|---|
| Gender | Female |
| Speciality | Certified Nurse Midwife (cnm) |
| Experience | 7 Years |
| Location | 21 Dupont Ave, White Plains, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104352160 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | 001794 (New York) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Refuah Health Center Inc | 4880584416 | 70 |
News Archive
The fear, anxiety and stress associated with the COVID-19 pandemic has taken a toll on mental health. But a new study suggests these symptoms may be alleviated through safe and convenient online mindfulness practices.
A recent study conducted by researchers from the US aimed to measure the impact of severity of COVID-19 on memory B cell response and characterize changes in the memory B cell compartment during the period between recovery and five months after symptom onset. This study is available on the bioRxiv* preprint server.
Aerovance Inc. has announced that it has received clearance from the U.S. Food and Drug Administration (FDA) and the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) to initiate Aerovance's Phase IIb clinical trial, AeroTrial(TM), of inhaled dry powder Aerovant in patients with uncontrolled asthma.
Scientists from two U.S. national laboratories, industry and academia today launched an unprecedented effort to transform the way cancer drugs are discovered by creating an open and sharable platform that integrates high-performance computing, shared biological data from public and industry sources and emerging biotechnologies to dramatically accelerate the discovery of effective cancer therapies.
› Verified 8 days ago
| Entity Name | Refuah Health Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669470019 PECOS PAC ID: 4880584416 Enrollment ID: O20040317001392 |
News Archive
The fear, anxiety and stress associated with the COVID-19 pandemic has taken a toll on mental health. But a new study suggests these symptoms may be alleviated through safe and convenient online mindfulness practices.
A recent study conducted by researchers from the US aimed to measure the impact of severity of COVID-19 on memory B cell response and characterize changes in the memory B cell compartment during the period between recovery and five months after symptom onset. This study is available on the bioRxiv* preprint server.
Aerovance Inc. has announced that it has received clearance from the U.S. Food and Drug Administration (FDA) and the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) to initiate Aerovance's Phase IIb clinical trial, AeroTrial(TM), of inhaled dry powder Aerovant in patients with uncontrolled asthma.
Scientists from two U.S. national laboratories, industry and academia today launched an unprecedented effort to transform the way cancer drugs are discovered by creating an open and sharable platform that integrates high-performance computing, shared biological data from public and industry sources and emerging biotechnologies to dramatically accelerate the discovery of effective cancer therapies.
› Verified 8 days ago
| Entity Name | Planned Parenthood Hudson Peconic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285701672 PECOS PAC ID: 8921376138 Enrollment ID: O20170612002415 |
News Archive
The fear, anxiety and stress associated with the COVID-19 pandemic has taken a toll on mental health. But a new study suggests these symptoms may be alleviated through safe and convenient online mindfulness practices.
A recent study conducted by researchers from the US aimed to measure the impact of severity of COVID-19 on memory B cell response and characterize changes in the memory B cell compartment during the period between recovery and five months after symptom onset. This study is available on the bioRxiv* preprint server.
Aerovance Inc. has announced that it has received clearance from the U.S. Food and Drug Administration (FDA) and the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) to initiate Aerovance's Phase IIb clinical trial, AeroTrial(TM), of inhaled dry powder Aerovant in patients with uncontrolled asthma.
Scientists from two U.S. national laboratories, industry and academia today launched an unprecedented effort to transform the way cancer drugs are discovered by creating an open and sharable platform that integrates high-performance computing, shared biological data from public and industry sources and emerging biotechnologies to dramatically accelerate the discovery of effective cancer therapies.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Kari Odquist Kohl, CNM 21 Dupont Ave, White Plains, NY 10605-3537 Ph: (914) 686-0406 | Ms Kari Odquist Kohl, CNM 21 Dupont Ave, White Plains, NY 10605-3537 Ph: (914) 686-0406 |
News Archive
The fear, anxiety and stress associated with the COVID-19 pandemic has taken a toll on mental health. But a new study suggests these symptoms may be alleviated through safe and convenient online mindfulness practices.
A recent study conducted by researchers from the US aimed to measure the impact of severity of COVID-19 on memory B cell response and characterize changes in the memory B cell compartment during the period between recovery and five months after symptom onset. This study is available on the bioRxiv* preprint server.
Aerovance Inc. has announced that it has received clearance from the U.S. Food and Drug Administration (FDA) and the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) to initiate Aerovance's Phase IIb clinical trial, AeroTrial(TM), of inhaled dry powder Aerovant in patients with uncontrolled asthma.
Scientists from two U.S. national laboratories, industry and academia today launched an unprecedented effort to transform the way cancer drugs are discovered by creating an open and sharable platform that integrates high-performance computing, shared biological data from public and industry sources and emerging biotechnologies to dramatically accelerate the discovery of effective cancer therapies.
› Verified 8 days ago
Elanor Schoomer, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 175 Tarrytown Rd, White Plains, NY 10607 Phone: 914-761-6566 Fax: 914-948-5533 | |
Kathy Lynn Herron, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 1241 Mamaroneck Ave, White Plains, NY 10605 Phone: 914-421-1500 Fax: 914-421-1501 | |
Ms. Carol Ann Hughes, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 175 Tarrytown Rd, White Plains, NY 10607 Phone: 914-761-6566 | |
Ms. Catherine Burger Keith, C.N.M Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 210 Westchester Ave, White Plains, NY 10604 Phone: 914-682-0732 Fax: 914-682-6403 | |
Ms. Robin H Bradley, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 1241 Mamaroneck Ave, White Plains, NY 10605 Phone: 914-421-1500 Fax: 914-421-1501 | |
Lucille Catherine Milne, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 15 N Broadway, White Plains, NY 10601 Phone: 914-328-8444 Fax: 914-328-8414 |